NEW YORK, February 10, 2017 /PRNewswire/ --
On Thursday, the NASDAQ Composite ended the day at 5,715.18, up 0.58%;
On Thursday, shares in Denver, Colorado-based BioScrip Inc. ended the session 0.61% lower at $1.62 with a total volume of 1.40 million shares traded. BioScrip's shares have gained 2.53% in the last one month and 19.12% in the previous three months. Furthermore, the stock has advanced 4.52% in the past one year. The stock is trading 24.40% above its 50-day moving average. Moreover, shares of the Company, which provides home infusion services in the US, have a Relative Strength Index (RSI) of 58.27. BIOS complete research report is just a click away and free at:
Mechanicsburg, Pennsylvania headquartered Select Medical Holdings Corp.'s stock finished Thursday's session 1.59% higher at $12.80 with a total volume of 1.09 million shares traded. Over the last three months and the previous one year, Select Medical Holdings' shares have surged 11.79% and 62.23%, respectively. The Company's shares are trading above its 200-day moving average by 2.16%. Shares of Select Medical Holdings, which through its subsidiary, Select Medical Corporation, operates specialty hospitals and outpatient rehabilitation clinics in the US, are trading at a PE ratio of 13.54. Additionally, the stock has an RSI of 41.62.
On January 30th, 2017, research firm Wells Fargo downgraded the Company's stock rating from 'Outperform' to 'Market Perform'. The complimentary report on SEM can be downloaded at:
On Thursday, shares in Houston, Texas headquartered Nobilis Health Corp. recorded a trading volume of 373,422 shares. The stock ended the day 2.33% higher at $2.20. Shares of the Company are trading at a PE ratio of 3.97. Nobilis Health's stock has gained 11.11% in the past one year. The Company is trading below its 50-day and 200-day moving averages by 2.40% and 22.41%, respectively. Furthermore, shares of Nobilis Health, which together with its subsidiaries, acquires and manages ambulatory surgical centers and healthcare facilities in the US, have an RSI of 48.10. Sign up for your complimentary research report on HLTH at:
Health Insurance Innovations
Tampa, Florida-based Health Insurance Innovations Inc.'s stock advanced 1.54%, to close the day at $19.75. The stock recorded a trading volume of 137,000 shares. Health Insurance Innovations' shares have rallied 2.33% in the last one month, 221.14% in the previous three months, and 254.58% in the past one year. The Company's shares are trading 17.90% and 134.37% above its 50-day and 200-day moving averages, respectively. Shares of the Company, which operates as a developer, distributor, and administrator of cloud-based individual health and family insurance plans, and supplemental products in the US, are trading at a PE ratio of 31.45. Additionally, the stock has an RSI of 60.25. Get free access to your research report on HIIQ at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!